Live Breaking News & Updates on Homocystinuria Lead

Stay updated with breaking news from Homocystinuria lead. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023 - Synlogic (NASDAQ:SYBX)

- Poster presentation on SYNB1353 program for homocystinuria includes findings from process improvements to improve activity of methionine degradation - CAMBRIDGE, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) Synlogic, ....

United States , United Kingdom , David Lubkowicz , Drug Administration , Exchange Commission , Program Lead At Synlogic , International Conference On Microbiome Engineering , Synlogic Inc , International Conference , Microbiome Engineering , Engineered Bacteria , Homocystinuria Lead , Strain Engineering , Ginkgo Bioworks , Rare Pediatric Disease Designation , Fast Track , Orphan Drug Designation , Synthetic Biotic , Private Securities Litigation Reform Act , Synthetic Biotics ,